Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.86%6.65B | 2.16%12.76B | 1.22%6.22B | 5.74%12.49B | 6.17%6.15B | -10.49%11.81B | -26.49%5.79B | 22.37%13.19B | 68.32%7.87B | 47.03%10.78B |
| Operating income | 6.86%6.65B | 2.16%12.76B | 1.22%6.22B | 5.74%12.49B | 6.17%6.15B | -10.49%11.81B | -26.49%5.79B | 22.37%13.19B | 68.32%7.87B | 47.03%10.78B |
| Cost of sales | -9.75%-5.45B | -9.97%-10.31B | -6.85%-4.96B | -3.17%-9.38B | -3.14%-4.65B | 4.61%-9.09B | 8.72%-4.5B | -40.85%-9.53B | -68.09%-4.93B | -21.30%-6.77B |
| Operating expenses | -9.75%-5.45B | -9.97%-10.31B | -6.85%-4.96B | -3.17%-9.38B | -3.14%-4.65B | 4.61%-9.09B | 8.72%-4.5B | -40.85%-9.53B | -68.09%-4.93B | -21.30%-6.77B |
| Gross profit | -4.57%1.2B | -21.39%2.44B | -16.21%1.26B | 14.32%3.11B | 16.79%1.5B | -25.79%2.72B | -56.32%1.28B | -8.76%3.66B | 68.71%2.94B | 128.83%4.02B |
| Administrative expenses | 11.40%-460.42M | -7.26%-975.42M | -33.15%-519.66M | -16.99%-909.43M | 5.99%-390.27M | 20.68%-777.36M | 6.38%-415.14M | -51.96%-980.05M | -91.23%-443.44M | -25.22%-644.95M |
| Revaluation surplus | -1,065.12%-501K | 98.23%-43K | 98.13%-43K | -1,148.71%-2.43M | -763.98%-2.3M | -95.50%232K | --347K | --5.15M | ---- | ---- |
| -Changes in the fair value of investment property | -1,065.12%-501K | 98.23%-43K | 98.13%-43K | -1,148.71%-2.43M | -763.98%-2.3M | -95.50%232K | --347K | --5.15M | ---- | ---- |
| Impairment and provision | 3.73%-68.47M | 6.62%-130.89M | 9.54%-71.12M | -28.80%-140.17M | -45.05%-78.62M | 95.78%-108.83M | -447.99%-54.2M | -7,309.48%-2.58B | 78.92%-9.89M | 174.11%35.73M |
| -Other impairment is provision | 3.73%-68.47M | 6.62%-130.89M | 9.54%-71.12M | -28.80%-140.17M | -45.05%-78.62M | 95.78%-108.83M | -447.99%-54.2M | -7,309.48%-2.58B | 78.92%-9.89M | 174.11%35.73M |
| Special items of operating profit | -26.20%34.97M | 147.58%137.05M | 212.93%47.38M | -63.81%55.36M | -79.96%15.14M | 156.72%152.97M | -16.05%75.54M | -348.51%-269.71M | 83.18%89.98M | 63.56%108.53M |
| Operating profit | -1.18%704.27M | -30.19%1.47B | -31.68%712.65M | 6.33%2.11B | 17.18%1.04B | 1,368.04%1.99B | -65.43%890.21M | -104.46%-156.63M | 70.31%2.58B | 179.41%3.52B |
| Financing cost | -17.52%-41.07M | -26.96%-69.54M | -36.41%-34.95M | 2.55%-54.77M | -44.95%-25.62M | 8.62%-56.2M | 29.18%-17.67M | -247.99%-61.5M | -98.24%-24.96M | 38.81%-17.67M |
| Special items of earning before tax | 18.57%5.6M | -94.32%2.75M | -31.56%4.72M | 582.27%48.46M | 914.85%6.9M | 1,017.57%7.1M | -39.61%680K | ---774K | --1.13M | ---- |
| Earning before tax | -2.00%668.81M | -33.16%1.41B | -33.38%682.43M | 8.70%2.11B | 17.31%1.02B | 984.86%1.94B | -65.77%873.21M | -106.26%-218.9M | 70.15%2.55B | 184.54%3.5B |
| Tax | 2.71%-177.65M | 30.71%-375.33M | 21.98%-182.6M | -18.15%-541.65M | 22.58%-234.06M | -169.85%-458.42M | 50.99%-302.34M | 80.04%-169.88M | -75.07%-616.88M | -184.96%-851.06M |
| After-tax profit from continuing operations | -1.74%491.16M | -34.01%1.03B | -36.76%499.83M | 5.76%1.56B | 38.44%790.33M | 480.31%1.48B | -70.49%570.87M | -114.69%-388.78M | 68.63%1.93B | 184.41%2.65B |
| Earning after tax | -1.74%491.16M | -34.01%1.03B | -36.76%499.83M | 5.76%1.56B | 38.44%790.33M | 480.31%1.48B | -70.49%570.87M | -114.69%-388.78M | 68.63%1.93B | 184.41%2.65B |
| Minority profit | 2,805.30%18.88M | -51.19%11.04M | -107.73%-698K | -59.54%22.61M | -63.51%9.02M | 177.11%55.9M | 3,222.73%24.73M | -11,388.11%-72.49M | 23.99%-792K | -316.10%-631K |
| Profit attributable to shareholders | -5.64%472.27M | -33.75%1.02B | -35.94%500.53M | 8.33%1.54B | 43.06%781.31M | 549.80%1.42B | -71.78%546.14M | -111.95%-316.29M | 68.55%1.94B | 184.56%2.65B |
| Basic earnings per share | -20.00%0.04 | -35.71%0.09 | -28.57%0.05 | 7.69%0.14 | 40.00%0.07 | 533.33%0.13 | -72.22%0.05 | -111.54%-0.03 | 63.64%0.18 | 188.89%0.26 |
| Diluted earnings per share | -20.00%0.04 | -35.71%0.09 | -28.57%0.05 | 7.69%0.14 | 40.00%0.07 | 533.33%0.13 | -72.22%0.05 | -111.54%-0.03 | 63.64%0.18 | 188.89%0.26 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.